Orthotopic syngeneic tumor models for preclinical evaluation of cancer immunotherapy strategies

被引:0
|
作者
Zhang, Juan
Guo, Sheng
Wang, Zhensheng
Li, Zhongliang
Qiao, Meng
Shi, Qian
机构
关键词
D O I
10.1158/1538-7445.AM2016-5176
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5176
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Deep Immuno-profiling of syngeneic tumor mouse models for preclinical studies
    Joachim, Anais
    Maturin, Emilie
    Mello, Marielle
    Hadjem, Lillia
    Grange, Magali
    Deas, Olivier
    Zarubica, Ana
    Malissen, Bernard
    Luche, Herve
    CANCER RESEARCH, 2023, 83 (07)
  • [22] Deep immuno-profiling of syngeneic tumor mouse models for preclinical studies
    Joachim, Anais
    Maturin, Emilie
    Mello, Marielle
    Hadjem, Lilia
    Grange, Magali
    Deas, Olivier
    Zarubica, Ana
    Malissen, Bernard
    Luche, Herve
    Romagne, Francois
    Blanchin, Stephanie
    CANCER RESEARCH, 2024, 84 (06)
  • [23] Pharmacokinetic of tumor FDG uptake in subcutaneous and orthotopic preclinical models of breast cancer - Influence of administration route
    Oudot, A.
    Vrigneaud, J. M.
    Raguin, O.
    Guillemin, M.
    Provent, P.
    Collin, B.
    Brunotte, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S477 - S477
  • [24] Establishment of orthotopic syngeneic models using bioluminescence imaging to recapitulate the tumor microenvironment for evaluation of immuno-oncology therapies
    Miller, Bryan
    Song, Yanrui
    Davis, Jason
    Kumari, Rajendra
    Ouyang, Davy Xuesong
    Li, Henry Qixiang
    Yin, Yinfei
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [25] Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer
    Lal, Jessica Castrillon
    Townsend, Madeline G.
    Mehta, Anita K.
    Oliwa, Madisson
    Miller, Eric
    Sotayo, Alaba
    Cheney, Emily
    Mittendorf, Elizabeth A.
    Letai, Anthony
    Guerriero, Jennifer L.
    BREAST CANCER RESEARCH, 2021, 23 (01)
  • [26] Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
    Lv, Xiangdong
    Dobrolecki, Lacey E.
    Ding, Yao
    Rosen, Jeffrey M.
    Lewis, Michael T.
    Chen, Xi
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (159):
  • [27] Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer
    Jessica Castrillon Lal
    Madeline G. Townsend
    Anita K. Mehta
    Madisson Oliwa
    Eric Miller
    Alaba Sotayo
    Emily Cheney
    Elizabeth A. Mittendorf
    Anthony Letai
    Jennifer L. Guerriero
    Breast Cancer Research, 23
  • [28] Characterization of the tumor microenvironment of key suppressive myeloid populations in 11 commonly used preclinical syngeneic cancer models
    Ringgaard, Lars
    Christensen, Esben
    Kristensen, Lotte K.
    Stavnsbjerg, Camilla
    Kjaer, Andreas
    Hansen, Anders E.
    Andresen, Thomas L.
    CANCER RESEARCH, 2019, 79 (13)
  • [29] Comparison of xenograft and syngeneic cancer cachexia models for preclinical drug testing
    Draheim, Kyle
    Gietl, Diana
    Shinn, Karyn
    Durham, William
    Zhao, Fei
    Thompson, Caitlin
    Baldwin, Alexis
    Harris, Glenn
    Hall, Chassidy
    Fadden, Patrick
    Avrutskaya, Anya
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models
    Saito, Yasuyuki
    Iida-Norita, Rie
    Afroj, Tania
    Refaat, Alaa
    Hazama, Daisuke
    Komori, Satomi
    Ohata, Shinya
    Takai, Tomoko
    Oduori, Okechi S.
    Kotani, Takenori
    Funakoshi, Yohei
    Koma, Yu-Ichiro
    Murata, Yoji
    Yakushijin, Kimikazu
    Matsuoka, Hiroshi
    Minami, Hironobu
    Yokozaki, Hiroshi
    Manz, Markus G.
    Matozaki, Takashi
    FRONTIERS IN IMMUNOLOGY, 2023, 14